Michael A. Channing - Concepedia

Author

Michael A. Channing

Also Known As

M A Channing, M Channing, M. A. CHANNING, M. A. Channing, M. Channing, M.A. Channing, Michael A Channing, Michael A. Channing, Michael Almy Channing, Michael Channing

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institutes of Health Clinical Center National Institute of Mental Health National Institute on Aging National Institute of Neurological Disorders and Stroke

About

Michael A. Channing is an author at National Institutes of Health specializing in medicine, engineering, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	12	13	1K
2	Medicine	12	12	1.3K
3	Natural Sciences	7	7	483
4	Health Sciences	6	6	549
5	Social Sciences	2	2	281

Michael A. Channing

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [<sup>18</sup>F]Cyclofoxy and Positron Emission Tomography Richard E. Carson, Michael A. Channing, Ronald G. Blasberg, Journal of Cerebral Blood Flow & Metabolism EngineeringPharmacotherapyExperimental PharmacologyPhysiologically-based Pharmacokinetic ModelingRegional Brain Radioactivity	1993	377
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. N Patronas, Giovanni Di Chiro, Rodney A. Brooks, Radiology Pet-mriRecurrent GliomasBrain LesionGliomaPositron Emission Tomography	1982	300
{<sup>18</sup>F}fluorodeoxyglucose positron emission tomography in refractory complex partial seizures William H. Theodore, Michael Newmark, Susumu Satô, Annals of Neurology Social SciencesPositron Emission TomographyFrontal LobeNeurologyNeuropathology	1983	250
CEREBRAL GLUCOSE UTILIZATION, AS MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN 21 RESTING HEALTHY MEN BETWEEN THE AGES OF 21 AND 83 YEARS Ranjan Duara, Richard Margolin, Elizabeth A. Robertson‐Tchabo, Brain	1983	229
Disposition requirements for binding in aqueous solution of polar substrates in the cyclohexaamylose cavity Raymond J. Bergeron, Michael A. Channing, George Gibeily, Journal of the American Chemical Society EngineeringChemical AnalysisAltmetric Attention ScorePolar EnvironmentsOrganic Chemistry	1977	202
Dependence of cycloamylose-substrate binding on charge Raymond J. Bergeron, Michael A. Channing, Kathy Ann McGovern Journal of the American Chemical Society Cycloamylose-substrate BindingMolecular SciencesEngineeringChemical MeasurementBiochemistry	1978	101
Kinetic Analysis of the 5-HT<sub>2A</sub> Ligand [<sup>11</sup>C]MDL 100,907 Hiroshi Watabe, Michael A. Channing, Margaret G. Der, Journal of Cerebral Blood Flow & Metabolism	2000	82
PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy William H. Theodore, Richard E. Carson, Paul Andreasen, Epilepsy Research Positron Emission TomographyEngineeringPet ImagingFunctional SelectivityMedicine	1992	74
Brain incorporation of [1–11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography Michael Chang, Toshinari Arai, Lois M. Freed, Brain Research Brain DevelopmentHypercapnic MonkeysBrain ScienceSensory SystemsPositron Emission Tomography	1997	72
Brain Incorporation of [<sup>11</sup>C]Arachidonic Acid in Young Healthy Humans Measured with Positron Emission Tomography Giampiero Giovacchini, Michael Chang, Michael A. Channing, Journal of Cerebral Blood Flow & Metabolism	2002	69

Page 1